MdMashup Profile Banner
MashupMD Profile
MashupMD

@MdMashup

Followers
703
Following
364
Media
313
Statuses
1K

MashupMD is a medical platform that links specialists with the social media conversations going on in their fields. Follow for news in health care and medicine.

Joined October 2019
Don't wanna be here? Send us removal request.
@MdMashup
MashupMD
3 days
🏆September was an exciting month at @cancer_nurses! Faith Selchick, DNP, RN, AGNP-BC, AOCNP, OCN, was honored with the Third Annual CARE Award. See the celebration and other September highlights, including #IASLC2025 and Blood Cancer Awareness Month. https://t.co/0Opdal6VyT
0
0
0
@MdMashup
MashupMD
3 days
🩺This month in Nephron Land with @kidney_boy: Apple Watch hypertension detection, new ACC/AHA BP guidelines, KDIGO’s IgA update, and highlights from GlomCon Hawaii. NephJC’s annual fund drive is now live to support peer review. ➡️ https://t.co/FoqiuDFYFC
0
2
3
@MdMashup
MashupMD
4 days
💡Check out this month's trending @JACCJournals articles: Cardiogenic Preshock, Global Burden of Disease, and more. This curated list highlights the most talked-about studies on social media, complete with exclusive commentary for MashupMD readers. https://t.co/L8k0u2AwFE
0
0
0
@MdMashup
MashupMD
4 days
🫀This week, @drjkahn reviews why cardiac inflammation is discussed but rarely measured, insights from a supercentenarian’s genome, how poor sleep accelerates brain aging, and how olive oil and plant-based diets support longevity and planetary health. 🔗 https://t.co/D9LuQZczgJ
0
1
1
@GUOncologyNow
GU Oncology Now
9 days
❗️ An update on the phase 2 LUNAR trial presented by @AmarUKishan of @UCLA has demonstrated the benefits of #PSMA–targeting RLT combined with metastasis-directed SBRT for the treatment of patients with oligometastatic hormone-sensitive #prostate cancer:
Tweet card summary image
guoncologynow.com
The combination of 177Lu-PSMA with SBRT met the primary end point of the phase 2 LUNAR trial.
0
1
0
@MdMashup
MashupMD
11 days
🆕 New this week from @Drjkahn: Lipoprotein(a) is the leading genetic CVD risk factor yet <1% are tested. Sleep & cardiometabolic health in the news, CBT-I for insomnia, hydration & longevity, mangoes in type 1 diabetes, and more. 🔗 https://t.co/mfkuGYGkMM
0
1
1
@cancer_nurses
Cancer Nursing Today
16 days
🏆 We’re proud to announce that Faith Selchick, DNP, RN, AGNP-BC, AOCNP, OCN, of @WMCHealth, is the recipient of Third Annual CARE Award! 👏 Please join us in congratulating her! ➡️ Hear what the award means to her: https://t.co/jDkYAzZLJf #CAREaward2025 #CancerNursesCARE
0
1
1
@MdMashup
MashupMD
13 days
🍂Fall is here and @Kidney_boy is sipping a PSL while thinking about potassium. He reviews new data showing higher mortality if you stop RASi after hyperkalemia and the old papers behind “Lasix for K.” ➡️Read more: https://t.co/9YlbKadGbk
0
1
5
@MdMashup
MashupMD
23 days
💡This week, @Drjkahn highlights insomnia’s link to brain aging, heart disease as the top U.S. killer, underrecognized ATTR cardiomyopathy, and new evidence on niacin, diet, semaglutide, and homocysteine. Learn more: https://t.co/TOEPQYTyg7
0
1
3
@Blood_Cancers
Blood Cancers Today
26 days
🙌 Drs. @IrenemGhobrial and @RomanosSP, of @DanaFarber, shared their research on SWIFT-seq, a novel, single cell, sequencing-based blood test for multiple #myeloma that could enable molecular profiling from the blood. 📺 Watch here! https://t.co/AnOHpKIUVa
0
1
2
@GUOncologyNow
GU Oncology Now
1 month
📺 In a new video series, Dr. Sandip Prasad of Atlantic Health System provides insight into the current treatment landscape for low-grade, intermediate-risk non-muscle invasive #bladdercancer, and the integration of the recent FDA-approved UGN-102 treatment into clinical
0
1
0
@MdMashup
MashupMD
1 month
📈 Trending interventional articles: renal denervation, VENUS-A, and more. Check out the most popular @JACCJournals: Cardiovascular Interventions papers on social media, curated for MashupMD readers. 🔗 https://t.co/JLXh7KiL1j
0
0
1
@MdMashup
MashupMD
1 month
📈 Check out trending @JACCJournals articles: pericarditis, high blood pressure guideline, and more with commentary curated exclusively for MashupMD readers. ➡️ https://t.co/nWsvPAvc1J
0
0
1
@MdMashup
MashupMD
1 month
📖 The August issue of @JCardFail is here! Explore new research from JCF-Intersections, a joint HFSA/ASPC statement on Prevention & Heart Failure, and the call for papers on Infiltrative & Inflammatory Cardiomyopathies. Read more: https://t.co/vkiVRddoZX
0
0
0
@MdMashup
MashupMD
1 month
📊CRC rates have held steady for decades, but @Marshalj23 explains why screening works when you consider population growth. New tools can help save even more lives. Read more: https://t.co/7V1Rok7jW0
0
0
1
@CardioCareToday
CardiocareToday.com
2 months
🧬 DNA isn’t fixed—it responds. New @CircAHA study: Better Life’s Essential 8 = healthier DNA methylation patterns. ➡️ Results: Up to 32% lower CVD risk 40% lower CVD death Lifestyle writes on your DNA. https://t.co/IGt0Q5aod5 #HeartHealth #CardioX #CardioTwitter
Tweet card summary image
cardiocaretoday.com
Epigenetic signatures tied to Life’s Essential 8 link better heart health to lower disease and death risk.
0
1
0
@GUOncologyNow
GU Oncology Now
2 months
🔎 As it can be challenging to characterize anatomically-distinct disease between #UTUC and #bladdercancer molecularly, a recent study sought to determine and compare the somatic, germline, and immunologic landscapes of both:
0
1
0
@MdMashup
MashupMD
2 months
Editors at @Lung_Cancers are counting down to #WCLC25 in Barcelona 🇪🇸 Sept 6–9! Look for highlights on immunotherapy, NSCLC care, FDA approvals, and more. Catch up on #WCLC24 and stay tuned for more! 📢 https://t.co/T3yzlABEok
0
1
2
@MdMashup
MashupMD
2 months
New from @Drjkahn: New blood pressure guidelines after 8 years. Almonds may protect DNA. Cystatin C outperforms creatinine in heart failure. EMF risk for infants. Plus myths, curcumin, conch shell therapy and lithium for dementia. ➡️Read more: https://t.co/t27DMIVKzZ
0
1
1
@Blood_Cancers
Blood Cancers Today
2 months
In an era of progress, one of the next goal posts in #myeloma is successful development of trispecifics. Read our latest feature on evolving targeted approaches in myeloma, with insight from @JoshuaRichterMD, @MMBaljevicMD, and @HangQuach1. 📖 https://t.co/Rj3tDmhiTZ
1
4
12